Business
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2025, ended March 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on April 30, 2025.
About this update from Accuray Incorporated
[{"type":"text","content":"MADISON, Wis., April 16, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2025, ended March 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on April 30, 2025.","length":278,"tagName":"p"},{"type":"image","alt":"Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)","displaySize":"","headline":null,"caption":"Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":63,"url":"https://media.zenfs.com/en/prnewswire.com/8d559378b9aa528dfc02aa2f91aff376"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OyBvlePxn41ydvo8OkT8HQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTExMTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/8d559378b9aa528dfc02aa2f91aff376","width":400,"height":63}},"href":"https://mma.prnewswire.com/media/320376/accuray_incorporated_logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-877-344-7529 (USA) or 1-412-317-0088 (international), conference ID: 8141169.","length":336,"tagName":"p"},{"type":"text","content":"A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2025.","length":289,"tagName":"p"},{"type":"text","content":"About AccurayAccuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get...